We previously reported that expression level of LIM (ENH, PDLIM5) was significantly and commonly increased in the brains of patients with bipolar disorder, schizophrenia, and major depression. Expression of LIM was decreased in the lymphoblastoid cells derived from patients with bipolar disorders and schizophrenia. LIM protein reportedly plays an important role in linking protein kinase C with calcium channel. These findings suggested the role of LIM in the pathophysiology of bipolar disorder and schizophrenia. To further investigate the role of LIM in these mental disorders, we performed a replication study of gene expression analysis and performed genetic association studies. Upregulation of LIM was confirmed in the independent sample set obtained from Stanley Array Collection. No effect of sample pH or medication was observed. Genetic association study revealed the association of single nucleotide polymorphism (SNP)1 (rs10008257) with bipolar disorder. In an independent sample set, SNP2 (rs2433320) close to SNP1 was associated with bipolar disorder. In total samples, haplotype of these two SNPs was associated with bipolar disorder. No association was observed in case-control analysis and family-based association analysis in schizophrenia. These results suggest that SNPs in the upstream region of LIM may confer the genetic risk for bipolar disorder.
The role of genetic factors in bipolar disorder has been well established from twin, adoption, and family studies. 1 Extensive linkage analyses suggested many candidate loci. 2 In such loci, genes having functions related to bipolar disorder were examined as candidate genes, and several promising results have been reported. Among them, association with G72 at 13q34 has been replicated in several studies. [3] [4] [5] The other strategy to identify candidate genes is gene expression analysis. Mirnics et al 6 performed gene expression analysis using cDNA micoarray and reported that RGS4 was downregulated in the postmortem brains of patients with schizophrenia. They further examined the association of RGS4 with schizophrenia and found a positive association. 7 Several studies confirmed this finding. [8] [9] [10] A similar approach to identify candidate genes may also be effective for bipolar disorder.
We have performed comprehensive gene expression analysis of the frontal lobes obtained from Stanley Foundation Brain Bank using oligonucleotide microarray. 11 By analyzing 50 brains, we found that two genes, LIM and PRPF4B, were commonly altered in three mental disorders, bipolar disorder, schizophrenia, and major depression. Of the two genes, upregulation of LIM in the postmortem brain was confirmed by RT-PCR. Subsequently, we also found that LIM was significantly downregulated in the lymphoblastoid cell lines from patients with bipolar disorder. Since we cultured lymphoblastoid cells for more than 1 month after blood collection, effects of drugs and secondary effects of other confounding factors, such as endocrinological abnormalities, can be ruled out in this analysis.
Next, we performed a replication study of LIM expression in lymphoblastoid cells. 12 Reduced expression was confirmed in the extended samples with bipolar I disorder (N ¼ 26). We also found that LIM was significantly downregulated in bipolar II disorder (N ¼ 10) and schizophrenia (N ¼ 13). Thus, we speculated that regulation of LIM might be genetically impaired in bipolar disorder and other mental disorders.
LIM encodes an adopter protein connecting protein kinase C (PKC) e and N-type calcium channel. 13 Altered PKC activity in peripheral blood cells of bipolar patients is reported.
14 Furthermore, altered calcium signaling has been postulated as an important pathophysiological mechanism of this disorder. 15 Thus, it is reasonable to hypothesize that genetic variation of LIM causes genetically determined dysregulation of LIM, which causes calcium-signaling abnormalities in bipolar disorder.
LIM is located at 4q22, 16 for which some linkage signal has been detected in bipolar disorder 17 and schizophrenia. 18 Only a few studies revealed the loci in 4q for bipolar disorder [19] [20] [21] or schizophrenia. [22] [23] [24] Although the support by linkage studies is marginal, above-mentioned findings by gene expression analyses seemed strong enough to start genetic association analysis of this gene in bipolar disorder.
Here, we performed a replication study of altered expression levels of LIM in a larger number of samples of postmortem prefrontal cortex of bipolar disorder and schizophrenia obtained from the Stanley Array Collection, and analyzed possible confounding factors. We further performed association study of LIM in bipolar disorder and schizophrenia. While LIM was not associated with schizophrenia, it was associated with bipolar disorder, which was replicated in a different sample set. These results suggest that polymorphisms of LIM may confer a genetic risk for bipolar disorder.
Subjects and methods

RNA samples
RNA samples extracted from the prefrontal cortices (Broadmann's Area 46) were donated by the Stanley Array Collection. They contain total RNA samples from 35 individuals in each of three diagnostic groups (BD, SZ, and controls). Diagnoses was made according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (American Psychiatric Association). Detailed information about the diagnosis, and summary of demographic variables of each diagnostic group can be found at the website (http:// www.stanleyresearch.org/programs/brain_collection. asp).
Real-time quantitative RT-PCR
In all, 3-5 mg of total RNA was used for cDNA synthesis by olgo(dT) and SuperScript II reverse transcriptase (Invitrogen). RT-PCR using SYBER/ GREEN I (Applied Biosystems, Foster city, CA, USA) was performed with an ABI PRISM 7900HT (Applied Biosystems). The comparative C t method was used for quantification according to the manufacture's protocol (Applied Biosystems). Measurement of delta C t was carried out at least in triplicate. Amplification of the single product was confirmed by monitoring the dissociation curve and by gel electrophoresis. We used two control genes (GAPDH and CFL1) for normalization to control for possible fluctuations in quantitative values of the target transcripts. The validity of the use of CFL1 as an internal control gene in postmortem brain samples was shown previously. Primer pairs used in this study were according to the previous report.
11 Among males and 65 females). They were diagnosed with the consensus of two senior psychiatrists without using any structured interviews, or were diagnosed by a senior psychiatrist after an interview using SCID-IV (Structured Clinical Interview for DSM-IV). Controls were selected from students, nurses, office workers, and doctors in participating institutes, and their friends. A senior psychiatrist interviewed them and they did not have major mental disorders. Only a part of them were interviewed using a structured interview, Mini-International Neuropsychiatric Interview (M.I.N.I.). 25 The replication sample set was collected in the Tokyo Medical and Dental University, Hamamatsu University School of Medicine, and Lab. for Molecular Psychiatry ('MPS' samples). These include 240 patients with bipolar disorder (51.2713.1 years old, 132 males and 108 females) and 240 controls (51.4710.7 years old, 120 males and 120 females).
For the quantification of copy number of LIM gene, 28 patients with bipolar disorder were selected from 'MDMD' samples.
Subjects for genetic analyses: schizophrenia Subjects for the case-control analysis consist of 570 patients with schizophrenia (48.6712.0 years old, 285 males and 285 females) and an equal number of control subjects (48.4711.8 years old, 285 males and 285 females) collected by the Laboratory for Molecular Psychiatry. Control subjects were recruited from hospital staff and their acquaintances. They were interviewed by an experienced psychiatrist without using structured interviews and found not to have psychoses. Most of the controls in the MPS samples are included in this control group. All were Japanese. Diagnosis of the patients by DSM-IV criteria was made by consensus of two psychiatrists based on unstructured interviews of the patients, chart reviews, and information from family members and hospital staff.
We presumed that all these subjects were unrelated to each other, but it cannot be totally ruled out that some of the patients were related, because the ethics policy of the Japanese Government requires stringent anonymity.
The subjects for TDT analysis consisted of 124 families: 80 trios (schizophrenic offspring and their parents), 15 probands with one parent, and 13 probands with affected siblings, and 30 probands with discordant siblings. 26 They were diagnosed according to DSM-IV criteria by at least two experienced psychiatrists, on the basis of direct interviews, available medical records, and information from hospital staff and relatives.
The ethics committee of RIKEN and participating institutes approved the present study, and written informed consent was obtained from all participants.
Genotyping
Genotyping was performed using commercially available TaqMan probes and ABI7900HT according to the protocol recommended by the manufacturer.
Quantitative genomic PCR (gQ-PCR)
The copy number of LIM gene was analyzed by the real-time PCR method using SYBR/GREEN dye (Applied Biosystems). MLC1 was used as a single copy control gene. For the gQ-PCR, DNA solution was once quantified by the ultraviolet spectrophotometer, and again quantified by TaqMan assay using RnaseP (Applied Biosystems). For the quality control, a gene on the X chromosome (PF2 K) was also examined using SYBR/GREEN dye, and separation between males and females was confirmed. The DNA samples with intermediate copy number of X chromosome gene were regarded as having poor quality and were not used for further analysis. Sequences of primers and probes for these analyses except for RNaseP will be provided upon request.
Data analysis
The Mann-Whitney U test was used for comparison of expression level of LIM between control and bipolar disorder or schizophrenia.
Family-based association analysis was performed by pedigree disequilibrium test (PDT) program, v3.12. 27 Extended transmission disequilibrium test (ETDT) algorithm, v2.2, 28 was also performed in 80 complete trios. Detailed methods for data analysis were described elsewhere. 26 For the haplotype-based TDT analysis, the TRANSMIT program, v2.5.4, 29, 30 was used.
Linkage disequilibrium (LD) patterns were assessed in Japanese controls by the standardized disequilibrium coefficient (D 0 ) and the squared correlation 31 Assessment of sample stratification For population homogeneity assessment, a total of 20 single nucleotide polymorphisms (SNPs) were genotyped for all participants in this study, except for recently recruited 'sample Set C (N ¼ 196 each for schizophrenia and controls)'. STRUCTURE software 32 (http://pritch.bsd.uchicago.edu/software.html) was used to identify genetically similar diploid subpopulations by grouping individuals. In the application of this Markov chain Monte Carlo method, 1 000 000 replications were used for the burn-in period of the chain and for parameter estimation. The number of populations present in the sample (K) was unknown, so analysis was run at K ¼ 1, 2, 3, 4, and 5. From these results, best estimate of K was found by calculating posterior probabilities, Pr (K ¼ 1, 2, 3, 4, or 5), as described by Pritchard et al. 32 No evidence for stratification was identified in our samples, with a Pr (K ¼ 1) 40.99.
Results
Gene expression analysis
Patients with bipolar disorder (Po0. 01) and schizophrenia (Po0.05) showed significantly higher expression levels of LIM normalized by GAPDH in the postmortem cortex (Figure 1 ). This difference was also confirmed using the normalization by CFN1 (bipolar disorder, Po0.01, schizophrenia, P ¼ 0.07, respectively). There is a critical pH threshold in these samples. 33 When only the samples with pH of 6.4 or more were used for the analysis, patients with bipolar disorder and schizophrenia still showed higher levels of LIM/GAPDH (bipolar disorder, Po0.006, schizophrenia, P ¼ 0.050) and LIM/CFN1 (bipolar disorder, Po0003, schizophrenia, P ¼ 0.081).
To examine the effects of medication on the expression levels of LIM, we performed exploratory t-test between subjects with or without a particular class of drugs, antipsychotics, antidepressants, lithium, and valproate. However, none of them were significantly associated with mRNA expression of LIM (Table 1 ). There was no significant difference of LIM expression levels between suicide cases and nonsuicide cases (Table 1) .
Genetic association study
We genotyped 16 SNP markers surrounding LIM gene (Figure 2 ). The markers covering the genomic region and having higher heterozygocity were selected to enhance the information content. Minor allele frequency was between 0.23 and 0.50. Linkage disequilibrium was assessed by the D 0 and r 2 in the control subjects. Although the entire gene is within weak linkage disequilibrium, there seems to be several haplotype blocks in this region ( Table 2 ).
All SNP markers were within the Hardy-Weinberg Equilibrium (HWE) in the MDMD samples. Allele and genotype frequencies of the SNP1 (rs10008257) were significantly different between bipolar patients and controls (allele, P ¼ 0.0021; genotype, P ¼ 0.0048, by Fisher's exact probability test) ( Table 3 ). The difference of allele and genotype frequencies was statistically significant or close to significant even after the Bonferroni correction (P ¼ 0.03 and 0.07 after Bonferroni correction of 16 SNP markers).
To examine whether or not this is a false-positive finding, we further genotyped an independent sample set (MPS samples). Most of SNP markers were within HWE, except for three SNP markers (SNPs 9, 12, and 16) showing some deviation from HWE only in bipolar disorder subjects. Allele and genotype frequencies of SNP2 (rs2433320), close to SNP1, were significantly different between bipolar disorder patients and control subjects (allele, P ¼ 0.02; genotype, P ¼ 0.01). The other marker, SNP4 (rs2438146), was also associated with bipolar disorder (allele P ¼ 0.04, genotype, P ¼ 0.06) ( Table 4) .
Since the analyses in two independent sample sets showed the association in the upstream region of LIM, we further performed haplotype analysis (Table 5) . Haplotype of two SNPs (SNPs 1 and 2) showed significant association with bipolar disorder (P ¼ 0.03, global P-value by permutation test). Haplotype of three SNPs (SNPs 1, 2, and 3) also showed a tendency of association with bipolar disorder (P ¼ 0.06).
Quantitative genomic PCR
Recent studies suggested that copy number polymorphisms could be observed in many genes. 34 . In the analysis of bipolar disorder, genotype frequency was deviated from HWE only in bipolar disorder in MPS samples. This was mainly derived from a higher number of homozygotes than expected. This could implicate that copy number polymorphism or deletion of this gene might be associated with bipolar disorder. To further explore this possibility, we performed quantitative genomic PCR analysis to measure the copy number of this genomic region. In all, 22 patients homozygous for the SNP15 (rs951613) (C/C, n ¼ 5; T/T, n ¼ 17) and six patients heterozygous for this SNP (C/T, n ¼ 6) were examined. While copy number difference of PF2K on X chromosome between females and males was clearly Figure 3 Quantitative genomic PCR of LIM. PF2 K on X chromosome were also measured to verify the experimental procedures. PF2K/MLC1 clearly differentiate males and females. There is no difference of LIM/MLC1 between homozygotes and heterozygotes, suggesting that there is no copy number polymorphism or deletion of this gene. demonstrated, none of the patients homozygous for the SNP15 had lower LIM/MLC1 ratio ( Figure 3 ). This suggests that none of the patients tested had deletion of this region, and it is unlikely that there is copy number variation in this region.
Association studies in schizophrenia
Since original findings in DNA microarray analysis of the postmortem brains and lymphoblastoid cell lines suggested the association with schizophrenia, we further examined the association of LIM with schizophrenia (Table 6 ). There was no significant difference of allele and genotype frequencies between patients with schizophrenia and controls. Haplotype analysis of two or three SNPs also showed no significant association with schizophrenia. (Table 7 ). In the family-based association study, none of the SNPs were significantly associated with schizophrenia. None of two or three SNPs haplotypes were associated with schizophrenia (Table 8 ).
Discussion
In this study, upregulation of LIM in the postmortem frontal cortex of patients with bipolar disorder and schizophrenia was confirmed in a different sample set. The upregulation could not be explained by confounding factors, such as medications, pH, and suicide status. These findings support the pathogenetic Table 8 Family-based association analyses in schizophrenia LIM, encoding a protein named enigma homolog (ENH), was initially identified by two hybrid screenings of rat brain cDNA library to interact with the regulatory domain of PKCbI. Northern blot analysis showed that there are two isoforms of LIM, 1.9 kb mRNA predominantly expressed in heart and skeletal muscles and 4.4 kb mRNA expressed in various tissues including the brain. 35 This gene was recently renamed as PDLIM5.
LIM is named after the LIM domain, composed of 50-60 amino acids that are involved in proteinprotein interaction. Using an ENH-specific antibody, Maeno-Hikichi 13 found that ENH is expressed in various regions of the brain, most notably in the hippocampus, cortex, thalamus, hypothalamus, amygdala, and selected regions of the cerebellum. ENH was present in presynaptic nerve terminals, shown by colocalization with synapsin I. ENH coprecipitated with N-type, but not with P/Q-type calcium channels. ENH interacts with PKCe but not with a, b2, and g. Thus, ENH was regarded as an adaptor protein that forms the PKCe-ENH-N-type Ca 2 þ channel complex. ENH facilitated the PKC modulation of N-type Ca 2 þ channel, by interacting the a 1B subunit of calcium channel. They concluded that formation of a kinase-substrate complex by an adaptor protein, ENH, is the molecular basis of specificity and efficiency of cellular signaling.
Wang and Friedman 36 reported that cytosolic PKCe was reduced in the postmortem brain samples of patients with bipolar disorder. PKCe is a common target of mood stabilizers, lithium, and valproate. 37 Our group reported that calcium channel a 1A subunit gene was significantly downregulated in the postmortem brain samples of bipolar disorder patients. Calcium signaling linked with phosphoinositide pathway has been regarded as one of the important molecular cascades related to the pathophysiology of bipolar disorder. 15 These findings suggest that the impairment of molecular cascade from PKC to calcium channel, which controls intracellular calcium levels in neurons via G-protein-coupled receptors, may become a genetic risk factor of bipolar disorder.
While the function of ENH in the brain is well characterized, that in lymphocytes is still unknown. In addition, it is not known how PDLIM5 is regulated in the brain and lymphocytes. Thus, it is difficult to interpret why PDLIM5 mRNA expression was increased in the brain but decreased in the lymphoblastoid cells in bipolar disorder and schizophrenia. Considering the complex interaction of transcription factors in the regulation of gene expression depending on the tissue types, such findings in the opposite direction might have arisen from single nucleotide polymorphisms altering the binding of transcription machinery.
Recently, Arinami et al (personal communication) performed association analysis of LIM and schizophrenia and found that several SNPs were significantly associated with schizophrenia. Among the SNPs significantly associated with schizophrenia, rs2433320 was also examined in this study. No significant association of this SNP with schizophrenia was observed in this study. Considering that a larger number of case-control samples were tested in this study (570 schizophrenic patients and 570 controls, while only 278 patients and 462 controls were studied by Arinami et al) and that no association was found in family-based association analysis, it cannot be totally ruled out that their initial findings were false-positive results. However, when the data of these two studies were combined, AA genotype of rs2433320 was significantly associated with schizophrenia in the total sample (schizophrenia, 33/840 (3.9%), control, 19/1025 (1.9%), P ¼ 0.02, Fisher's exact probability test). Thus, it might be possible that this SNP confers a genetic risk for schizophrenia. Further studies are needed to draw a definite conclusion.
Since the SNPs associated with bipolar disorder were not the same in two independent case-control samples and the observed association in the MPS sample is marginal, the association observed in bipolar disorder should also be interpreted with caution.
Further replication studies in independent patient populations and using trio samples will be required to validate the apparent association between SNPs in the upstream region of LIM and bipolar disorder.
